Zucker diabetic fatty rat: A new model of impaired cutaneous wound repair with type II diabetes mellitus and obesity

Wound Repair and Regeneration

Volumn 19, Issue 4, 2011, Pages 515-525

  Slavkovsky, Rastislav ^a,b   Kohlerova, Renata ^b   Tkacova, Vlasta ^c   Jiroutova, Alena ^b   Tahmazoglu, Burak ^d   Velebny, Vladimir ^a   Rezačová, Martina ^b   Sobotka, Lubos ^b   Kanta, Jiri ^b  

^a CPN   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF PARDUBICE   (Czech Republic)

^d ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN FIBER; COLLAGEN TYPE 1; COLLAGENASE 3; ELASTIN; HYDROXYPROLINE; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE; STROMELYSIN;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; DERMIS; DIABETOGENESIS; DNA DETERMINATION; EPITHELIUM; EXCISION; FEMALE; GENE EXPRESSION; GRANULATION TISSUE; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPID DIET; MALE; MORPHOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCAR; SEX DIFFERENCE; TURNOVER TIME; WOUND CONTRACTION; WOUND HEALING; ZUCKER DIABETIC FATTY RAT;

ANIMALS; COLLAGEN TYPE I; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ELASTIN; FEMALE; GRANULATION TISSUE; HYDROXYPROLINE; INFLAMMATION; INTERLEUKIN-6; MALE; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 3; OBESITY; PEROXIDASE; RATS; RATS, ZUCKER; SEX FACTORS; SKIN; SUPPURATION; WOUND HEALING;

EID: 79960087685     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/j.1524-475X.2011.00703.x     Document Type: Article

References (39)

1. Gan D., Diabetes atlas, third edition. Brussels: International Diabetic Federation, 2007.
2. Bakker K., International consensus on the diabetic foot. Brussels: International Working Group on the Diabetic Foot, 1999.
3. Brem H, Tomic-Canic M., Cellular and molecular basis of wound healing in diabetes. J Clin Invest 2007; 117: 1219-22.
4. Ahmed N., Advanced glycation endproductsa-role in pathology of diabetic complications. Diabetes Res Clin Pract 2005; 67: 3-21. (Pubitemid 40037725)
5. Lobmann R, Ambrosch A, Schultz G, Waldmann K, Schiweck S, Lehnert H., Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002; 45: 1011-6. (Pubitemid 34762196)
6. Rees DA, Alcolado JC., Animal models of diabetes mellitus. Diabet Med 2005; 22: 359-70. (Pubitemid 40516231)
7. Michaels J, Churgin SS, Blechman KM, Greives MR, Aarabi S, Galiano RD, Gurtner GC., db/db mice exhibit severe wound-healing impairments compared with other murine diabetic strains in a silicone-splinted excisional wound model. Wound Repair Regen 2007; 15: 665-70. (Pubitemid 47493885)
8. Peterson RG., The Zucker diabetic fatty (ZDF) rata-lessons from a leptin receptor defect diabetic model. In:, Shafrir E, editor. Animal models of diabetes: frontiers in research. Boca Raton, FL: CRC Press, 2007: 103-18.
9. Finegood DT, McArthur MD, Kojwang D, Thomas MJ, Topp BG, Leonard T, Buckingham RE., Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death. Diabetes 2001; 50: 1021-9. (Pubitemid 32374532)
10. Leonard BL, Watson RN, Loomes KM, Phillips AR, Cooper GJ., Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Acta Diabetol 2005; 42: 162-70. (Pubitemid 43029835)
11. Peterson RG, Shaw WN, Neel MA, Little LA, Eichberg J., Zucker diabetic fatty as a model for non-insulin dependent diabetes mellitus. ILAR News 1990; 32: 16-9.
12. Danis RP, Yang Y., Microvascular retinopathy in the Zucker diabetic fatty rat. Invest Ophthalmol Vis Sci 1993; 34: 2367-71. (Pubitemid 23191268)
13. Kahn SE., The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am J Med 2000; 108 (Suppl. 6a): 2S-8S.
14. Sudre B, Broqua P, White RB, Ashworth D, Evans DM, Haigh R, Junien JL, Aubert ML., Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male zucker diabetic fatty rats. Diabetes 2002; 51: 1461-9. (Pubitemid 34826612)
15. Hurych J, Chvapil M., Methods of hydroxyproline determination. Kozarstvi 1962; 12: 317-23.
16. Bauer BS, Ghahary A, Scott PG, Iwashina T, Demare J, Russell JC, Tredget EE., The JCR: LA-cp rat a novel model for impaired wound healing. Wound Repair Regen 2004; 12: 86-92. (Pubitemid 38249139)
17. Goodson WH III, Hunt TK., Wound collagen accumulation in obese hyperglycemic mice. Diabetes 1986; 35: 491-5. (Pubitemid 16078465)
18. Greenhalgh DG., Tissue repair in models of diabetes mellitus. A review. Methods Mol Med 2003; 78: 181-9.
19. Keswani SG, Katz AB, Lim FY, Zoltick P, Radu A, Alaee D, Herlyn M, Crombleholme TM., Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds. Wound Repair Regen 2004; 12: 497-504. (Pubitemid 39314331)
20. Apikoglu-Rabus S, Izzettin FV, Turan P, Ercan F., Effect of topical insulin on cutaneous wound healing in rats with or without acute diabetes. Clin Exp Dermatol 2010; 35: 180-5.
21. Frank S, Stallmeyer B, Kämpfer H, Kolb N, Pfeilschifter J., Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 2000; 106: 501-9. (Pubitemid 30666383)
22. Wall SJ, Bevan D, Thomas DW, Harding KG, Edwards DR, Murphy G., Differential expression of matrix metalloproteinases during impaired wound healing of the diabetes mouse. J Invest Dermatol 2002; 119: 91-8. (Pubitemid 35304396)
23. Sahai A, Malladi P, Pan X, Paul R, Melin-Aldana H, Green RM, Whitington PF., Obese and diabetic db/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin. Am J Physiol Gastrointest Liver Physiol 2004; 287: G1035-43. (Pubitemid 39423696)
24. Phillips MS, Liu Q, Hammond HA, Dugan V, Hey PJ, Caskey CJ, Hess JF., Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 1996; 13: 18-9.
25. McFarland-Mancini MM, Funk HM, Paluch AM, Zhou M, Giridhar PV, Mercer CA, Kozma SC, Drew AF., Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor. J Immunol 2010; 184: 7219-28.
26. Mateo RB, Reichner JS, Albina JE., Interleukin-6 activity in wounds. Am J Physiol 1994; 266 (Part 2): R1840-4.
27. Lin ZQ, Kondo T, Ishida Y, Takayasu T, Mukaida N., Essential involvement of IL-6 in the skin wound-healing process as evidenced by delayed wound healing in IL-6-deficient mice. J Leukoc Biol 2003; 73: 713-21. (Pubitemid 38040449)
28. Gallucci RM, Sugawara T, Yucesoy B, Berryann K, Simeonova PP, Matheson JM, Luster MI., Interleukin-6 treatment augments cutaneous wound healing in immunosuppressed mice. J Interferon Cytokine Res 2001; 21: 603-9. (Pubitemid 32911666)
29. Fu XB, Yang YH, Sun TZ., Transforming growth factor beta 1 and interleukin 6 mRNA expression in wound tissues of patients with diabetic ulcers. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 1999; 13: 259-62.
30. Fahey TJ III, Sadaty A, Jones WG II, Barber A, Smoller B, Shires GT., Diabetes impairs the late inflammatory response to wound healing. J Surg Res 1991; 50: 308-13.
31. Saarialho-Kere UK, Pentland AP, Birkedal-Hansen H, Parks WC, Welgus HG., Distinct populations of basal keratinocytes express stromelysin-1 and stromelysin-2 in chronic wounds. J Clin Invest 1994; 94: 79-88. (Pubitemid 24218079)
32. Bullard KM, Mudgett J, Scheuenstuhl H, Hunt TK, Banda MJ., Stromelysin-1-deficient fibroblasts display impaired contraction in vitro. J Surg Res 1999; 84: 31-4. (Pubitemid 29391596)
33. Park CH, Lee MJ, Ahn J, Kim S, Kim HH, Kim KH, Eun HC, Chung JH., Heat shock-induced matrix metalloproteinase (MMP)-1 and MMP-3 are mediated through ERK and JNK activation and via an autocrine interleukin-6 loop. J Invest Dermatol 2004; 123: 1012-9. (Pubitemid 39586819)
34. de la Torre P, Diaz-Sanjuan T, Garcia-Ruiz I, Esteban E, Canga F, Munoz-Yague T, Solis-Herruzo JA., Interleukin-6 increases rat metalloproteinase-13 gene expression through Janus kinase-2-mediated inhibition of serine/threonine phosphatase-2A. Cell Signal 2005; 17: 427-35. (Pubitemid 39643061)
35. Okazaki I, Watanabe T, Hozawa S, Niioka M, Arai M, Maruyama K., Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery. Keio J Med 2001; 50: 58-65. (Pubitemid 33611653)
36. Vaalamo M, Mattila L, Johansson N, Kariniemi AL, Karjalainen-Lindsberg ML, Kahari VM, Saarialho-Kere U., Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol 1997; 109: 96-101. (Pubitemid 27305656)
37. Parks WC., Matrix metalloproteinases in repair. Wound Repair Regen 1999; 7: 423-32. (Pubitemid 30027564)
38. Kyriakides TR, Wulsin D, Skokos EA, Fleckman P, Pirrone A, Shipley JM, Senior RM, Bornstein P., Mice that lack matrix metalloproteinase-9 display delayed wound healing associated with delayed reepithelization and disordered collagen fibrillogenesis. Matrix Biol 2009; 28: 65-73.
39. Reiss MJ, Han YP, Garcia E, Goldberg M, Yu H, Garner WL., Matrix metalloproteinase-9 delays wound healing in a murine wound model. Surgery 2010; 147: 295-302.